Our results raise the possibility that SLFN12 may act in adenocarcinoma at least in part by its effects on c-myc and its downstream signals, but SLFN12 may affect a variety of transcription factors [11,12] and the interplay between them and their downstream effects is likely to be complex. This evidence concerns the gene MYC and adenocarcinoma.